arrow
P

Pedro Luiz Serrano Usón

einstein hospital israelita
H指数:18
被引数:1,437

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Social Progress Index as a Determinant of Healthcare Access and Treatment in Pancreatic Cancer

社会进步指数作为影响胰腺癌医疗可及性和治疗效果的决定因素

2026-06-090
OA
Periostin-positive stellate cells associated with perineural invasion in pancreatic adenocarcinoma

骨桥蛋白阳性星状细胞与胰腺腺癌中的神经周围浸润相关

2025-10-150
PRE
Immune checkpoint inhibitors combined with tyrosine kinase inhibitors for soft-tissue sarcomas: a systematic review and single-arm meta-analysis

免疫检查点抑制剂联合酪氨酸激酶抑制剂治疗软组织肉瘤:一项系统评价和单臂Meta分析

2025-10-010
OA
Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal junction adenocarcinoma: a network meta-analysis

Anjum MU,Naqvi SAA,Jajja SA,Raina A,Afzal MU,Faisal KS,等. 围手术期及新辅助疗法在胃癌和胃食管结合部腺癌中的疗效:一项网络Meta分析. Oncologist. (2025) 30:oyaf157. doi: 10.1093/oncolo/oyaf157.

2025-08-011
OA
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer

1671晚期胆道癌患者游离DNA改变的临床表现

2022-12-0165
OA
Recommendations for the treatment of vulvar cancer in settings with limited resources: Report from the International Gynecological Cancer Society consensus meeting
2022-09-204
OAAI
Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting
2022-08-185
OAAI